MDxHealth (MDXH) Expected to Announce Earnings on Wednesday

MDxHealth (NASDAQ:MDXH) is expected to be posting its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect MDxHealth to post earnings of ($0.21) per share and revenue of $22.67 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

MDxHealth Stock Down 0.3 %

NASDAQ:MDXH opened at $1.86 on Monday. MDxHealth has a 1-year low of $1.55 and a 1-year high of $3.85. The company has a 50-day moving average of $2.04 and a 200 day moving average of $2.21. The firm has a market cap of $87.72 million, a PE ratio of -1.22 and a beta of 1.34. The company has a debt-to-equity ratio of 3.14, a current ratio of 1.54 and a quick ratio of 1.45.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Lake Street Capital assumed coverage on shares of MDxHealth in a research note on Thursday, October 31st. They issued a “buy” rating and a $7.00 price objective for the company. Piper Sandler lowered their price objective on shares of MDxHealth from $8.00 to $6.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.